Sanofi targets more effective cell based vaccine for flu epidemic
Sanofi Pasteur has signed a deal with SK Chemicals to license cell culture vaccine technology as the US is hit by a flu epidemic, reportedly one of the worst in recent history, which has highlighted the need for a universal vaccine and more potent flu shots produced in cells instead of eggs. To get exclusive